DK2110132T3 - Anvendelse af deuteriumoxid som elastasehæmmer - Google Patents

Anvendelse af deuteriumoxid som elastasehæmmer

Info

Publication number
DK2110132T3
DK2110132T3 DK08007676.3T DK08007676T DK2110132T3 DK 2110132 T3 DK2110132 T3 DK 2110132T3 DK 08007676 T DK08007676 T DK 08007676T DK 2110132 T3 DK2110132 T3 DK 2110132T3
Authority
DK
Denmark
Prior art keywords
deuterium oxide
elastase inhibitor
elastase
inhibitor
deuterium
Prior art date
Application number
DK08007676.3T
Other languages
English (en)
Inventor
Thomas Prof Dr Bayerl
Original Assignee
D2 Bioscience Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D2 Bioscience Group Ltd filed Critical D2 Bioscience Group Ltd
Application granted granted Critical
Publication of DK2110132T3 publication Critical patent/DK2110132T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK08007676.3T 2008-04-20 2008-04-20 Anvendelse af deuteriumoxid som elastasehæmmer DK2110132T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08007676.3A EP2110132B1 (de) 2008-04-20 2008-04-20 Verwendung von Deuteriumoxid als Elastase-Inhibitor

Publications (1)

Publication Number Publication Date
DK2110132T3 true DK2110132T3 (da) 2014-04-28

Family

ID=39745317

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08007676.3T DK2110132T3 (da) 2008-04-20 2008-04-20 Anvendelse af deuteriumoxid som elastasehæmmer

Country Status (7)

Country Link
US (1) US20110076331A1 (da)
EP (2) EP2508189A3 (da)
CN (1) CN102014933A (da)
CA (1) CA2722065A1 (da)
DK (1) DK2110132T3 (da)
ES (1) ES2459198T3 (da)
WO (1) WO2009130615A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007031397A1 (de) 2007-07-05 2009-01-08 D2O Bioscience Group Ltd. Verwendung von Deuteriumoxid zur Behandlung von Virus-basierten Erkrankungen der Haut
DE102009003942A1 (de) * 2009-01-07 2010-07-08 D2O Biosience Group Ltd., Hamilton Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Auges
DE102009003992A1 (de) * 2009-01-07 2010-07-08 D2O Biosience Group Ltd., Hamilton Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Respirationstraktes
JP2011241154A (ja) * 2010-05-14 2011-12-01 Tokuyama Dental Corp アルギン酸類含有水性組成物
EP2833589A1 (en) 2013-08-02 2015-02-04 Alcatel Lucent Intermediate node, an end node, and method for avoiding latency in a packet-switched network
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
CN107847432A (zh) 2015-05-29 2018-03-27 西德奈克西斯公司 D2o稳定化的药物制剂

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028431A (en) * 1987-10-29 1991-07-02 Hercon Laboratories Corporation Article for the delivery to animal tissue of a pharmacologically active agent
US5223269A (en) * 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
US5233269A (en) * 1990-04-13 1993-08-03 Varian Associates, Inc. Vacuum tube with an electron beam that is current and velocity-modulated
IL107120A (en) 1992-09-29 1997-09-30 Boehringer Ingelheim Int Atomising nozzle and filter and spray generating device
HU214824B (hu) * 1994-03-23 1998-06-29 HYD Kutató-Fejlesztő Kft. Bőrbetegségek kezelésére és megelőzésére alkalmas kozmetikai, higiéniai, valamint szépség- és testápolási készítmények és eljárás azok előállítására
DE4427690A1 (de) 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
US6009876A (en) * 1997-05-20 2000-01-04 Yavitz; Edward Q. Method for modifying and reshaping collagen beneath the surface of skin
RU2083210C1 (ru) * 1995-09-13 1997-07-10 Николаева Ирина Сергеевна Средство для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическим и дегенеративными изменениями органов и тканей
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US6495579B1 (en) * 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US20030157187A1 (en) * 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
DE19742439C1 (de) 1997-09-26 1998-10-22 Boehringer Ingelheim Int Mikrostrukturiertes Filter
US20070129282A1 (en) * 1998-11-24 2007-06-07 Ahlem Clarence N Pharmaceutical treatments and compositions
US6958390B1 (en) * 2000-06-14 2005-10-25 Stratagene California Compositions and kits for herpes simplex virus type 1 and 2 nucleic acid detection
US20040086453A1 (en) * 2001-01-22 2004-05-06 Howes Randolph M. Compositions, methods, apparatuses, and systems for singlet oxygen delivery
WO2004026313A1 (en) * 2002-09-17 2004-04-01 Nippon Boehringer Ingelheim Co., Ltd. Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer.
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
DE10361944A1 (de) * 2003-12-31 2005-07-28 Viromics Gmbh Mittel zur Hemmung der Virusreplikation durch Regulation der Proteinfaltung
US7767215B2 (en) * 2004-06-29 2010-08-03 Mcka Llc Topical compositions for anti-aging and methods of using same
TW200808763A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds I
DE102006049185A1 (de) * 2006-10-18 2008-04-24 Bayerl, Thomas M., Prof. Dr. Verwendung von Deuteriumdioxid zur Behandlung von hyperproliferativen Erkrankungen der Haut
DE102007031397A1 (de) * 2007-07-05 2009-01-08 D2O Bioscience Group Ltd. Verwendung von Deuteriumoxid zur Behandlung von Virus-basierten Erkrankungen der Haut
DE102009003942A1 (de) * 2009-01-07 2010-07-08 D2O Biosience Group Ltd., Hamilton Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Auges

Also Published As

Publication number Publication date
EP2110132B1 (de) 2014-01-22
EP2508189A3 (de) 2012-11-07
US20110076331A1 (en) 2011-03-31
WO2009130615A2 (de) 2009-10-29
CN102014933A (zh) 2011-04-13
ES2459198T3 (es) 2014-05-08
EP2110132A1 (de) 2009-10-21
CA2722065A1 (en) 2009-10-29
WO2009130615A3 (de) 2010-03-18
EP2508189A2 (de) 2012-10-10

Similar Documents

Publication Publication Date Title
DK2315756T3 (da) 1,2,5-oxadiazoler som inhibitorer af indolamin-2,3-dioxygenase
DK2300465T3 (da) Imidazopyridinderivater som hæmmere af receptortyrosinkinaser
DK2242752T3 (da) Imidazolyl-biphenylimidazoler som hepatitis C-virus-inhibitorer
DK1981875T3 (da) Substituerede indolylalkylaminoderivater som inhibitorer af histondeacetylase
DK2475657T3 (da) 5-Alkynylthien-2-ylcarboxylsyrer som inhibitorer af flaviviridae-vira
DK2448938T3 (da) Pyrimidinoner som pi3k-inhibitorer
DK2421825T3 (da) Azetidinyldiamider som monoacylglycerollipase-inhibitorer
DK2086939T3 (da) Pyridiacarboxamid som II-beta-HSDI-inhibitorer
DK2317851T3 (da) Anvendelse af 5-fluorcytosin som fungicid
DK2139892T3 (da) Substituerede pyrimidodiazepiner nyttige som PLK1-inhibitorer
DK2419429T3 (da) Imidazopyraziner som inhibitorer af proteinkinaser
DK2125748T3 (da) Acylaminopyrazol som FGFR inhibitorer
DK2015754T3 (da) Anvendelse af dpp-iv-inhibitorer
ATE546444T1 (de) Amidophenoxyindazole als c-met-hemmer
DK2086960T3 (da) Nye inhibitorer af glutaminylcyclase.
BRPI0918602A2 (pt) composto (i)
DK2091945T3 (da) Nye inhibitorer af glutaminylcyclase
DK3208269T3 (da) Inhibitorer af c-fms-kinase
DK2111555T3 (da) Diagnosticering af præeklampsi
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
DK2421537T3 (da) Pyrazolylaminopyridiner som inhibitorer af FAK
BRPI0914057A2 (pt) edificação alta
DK2110132T3 (da) Anvendelse af deuteriumoxid som elastasehæmmer
BRPI0907122A2 (pt) Piridoindóis (1-azinona) substituídos
DK2405972T3 (da) Anvendelse af rosuvastatin lactoler som medikamenter